SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-158515
Filing Date
2022-05-24
Accepted
2022-05-24 16:08:37
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d362448ds3.htm S-3 268453
2 EX-1.2 d362448dex12.htm EX-1.2 185277
3 EX-4.8 d362448dex48.htm EX-4.8 325556
4 EX-5.1 d362448dex51.htm EX-5.1 14865
5 EX-5.2 d362448dex52.htm EX-5.2 6764
6 EX-23.1 d362448dex231.htm EX-23.1 1535
7 EX-FILING FEES d362448dexfilingfees.htm EX-FILING FEES 39329
8 GRAPHIC g362448g00a23.jpg GRAPHIC 595813
9 GRAPHIC g362448g00a24.jpg GRAPHIC 595586
10 GRAPHIC g362448g0521082151687.jpg GRAPHIC 2464
11 GRAPHIC g362448g0521084053221.jpg GRAPHIC 2464
  Complete submission text file 0001193125-22-158515.txt   2472118
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265173 | Film No.: 22956706
SIC: 2836 Biological Products, (No Diagnostic Substances)